The Phenylketonuria (PKU) Treatment Market was valued at USD 0.9 billion in 2024 and is projected to reach USD 1.8 billion by 2034, registering a CAGR of 7.5%. The growth of this market is underpinned by several factors, including the rising prevalence of PKU, advancements in treatment options, and increasing awareness among healthcare professionals and patients. The demand for effective...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek